http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010005844-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04W4-12 |
| filingDate | 1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010005844-A |
| titleOfInvention | Preventives for Reconstriction |
| abstract | The present invention relates to an agent for preventing restenosis after coronary intervention therapy, comprising the compound represented by the following formula (I) as an active ingredient. A novel use of this drug is to prevent restenosis after coronary intervention in patients with ischemic heart disease who have a severe degree of stenosis or who cannot cope with drug treatment.n n n <Formula I> |
| priorityDate | 1997-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.